Infusional anthracyclines: is slower better? If so, why?

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Oncogene·2020

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Psychological medicine·2016

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Oncogene·2013

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

British journal of cancer·2013

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Clinical pharmacology and therapeutics·2013

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Respiratory Depressant Interactions of Fentanyl and Xylazine and Their Reversal by Naloxone and Yohimbine in Mice.

Neuropharmacology·2026

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

JHEP reports : innovation in hepatology·2026

Syringeable hyaluronic acid-based hydrogel co-loaded with Cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy.

Biomedical materials (Bristol, England)·2026

Yunnan Baiyao inhibits EBV-positive nasopharyngeal carcinoma via ferritinophagy-dependent ferroptosis.

Tissue & cell·2026

Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis.

Journal of biochemical and molecular toxicology·2026

Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.

Annals of surgical oncology·2026

Related Experiment Videos

Infusional anthracyclines: is slower better? If so, why?

Related Concept Videos

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.

Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.

GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults.

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Respiratory Depressant Interactions of Fentanyl and Xylazine and Their Reversal by Naloxone and Yohimbine in Mice.

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

Syringeable hyaluronic acid-based hydrogel co-loaded with Cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy.

Yunnan Baiyao inhibits EBV-positive nasopharyngeal carcinoma via ferritinophagy-dependent ferroptosis.

Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis.

Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.

Related Experiment Videos

Infusional anthracyclines: is slower better? If so, why?

Related Concept Videos

Related Articles